Year: 2024
Type: article
Abstract: Summary Marginal zone lymphoma is a relatively rare disease with a usually indolent clinical course. In clinical terms, three major subtypes—i.e., extranodal, nodal, and splenic marginal zone lymphomas—are encountered, which have specific clinical features. Clinical progress, however, has been limited in recent years as they are mostly lumped together with follicular lymphoma under the term “indolent lymphomas” in clinical trials. A talk given at the 2024 Annual Meeting of the Austrian Society of Hematology and Oncology aimed to summarize clinically relevant topics and progress in the field of marginal zone lymphoma, which is summarized in the current article.
Authors: Markus Raderer, Barbara Kiesewetter
Institutions: University of Vienna, Medical University of Vienna
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,590
Funder: Medizinische Universität Wien
OpenAlex ID: W4404092218